Merck & Co., Inc. (MRK) Form 10-K Annual Reports
Merck & Co., Inc. (MRK) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MRK
CIK: 310158
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: NJ
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerGerald Flynn
Audit LocationFlorham Park, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 25-NSE | 2026-10-15 | — | 25-NSE Filing | 0000876661-26-000834 | View SEC Doc Filr Page |
| 8-K | 2026-10-13 | 2026-10-09 | 8-K | 0000310158-26-000237 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-30 | PRIMARY DOCUMENT | 0000310158-26-000234 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-30 | PRIMARY DOCUMENT | 0000310158-26-000232 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-30 | PRIMARY DOCUMENT | 0000310158-26-000230 | View SEC Doc Filr Page |
| 3 | 2026-09-01 | 2026-09-01 | PRIMARY DOCUMENT | 0000310158-26-000225 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-13 | PRIMARY DOCUMENT | 0000310158-26-000223 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001950047-26-008057 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-12 | PRIMARY DOCUMENT | 0000310158-26-000221 | View SEC Doc Filr Page |
| 144 | 2026-08-12 | — | 144 Filing | 0001950047-26-008012 | View SEC Doc Filr Page |
| 144 | 2026-08-12 | — | 144 Filing | 0001950047-26-008008 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | PRIMARY DOCUMENT | 0000310158-26-000219 | View SEC Doc Filr Page |
| 144 | 2026-08-11 | — | 144 Filing | 0001950047-26-007942 | View SEC Doc Filr Page |
| 144 | 2026-08-10 | — | 144 Filing | 0001950047-26-007905 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | PRIMARY DOCUMENT | 0000310158-26-000217 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | PRIMARY DOCUMENT | 0000310158-26-000215 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | PRIMARY DOCUMENT | 0000310158-26-000214 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-06 | PRIMARY DOCUMENT | 0000310158-26-000213 | View SEC Doc Filr Page |
| 10-Q | 2026-08-07 | 2026-06-30 | 10-Q | 0000310158-26-000212 | View SEC Doc Filr Page |
| 13F-HR | 2026-08-07 | 2026-06-30 | 13F-HR Filing | 0000310158-26-000210 | View SEC Doc Filr Page |
| 144 | 2026-08-06 | — | 144 Filing | 0001950047-26-007763 | View SEC Doc Filr Page |
| 144 | 2026-08-06 | — | 144 Filing | 0001950047-26-007761 | View SEC Doc Filr Page |
| 144 | 2026-08-05 | — | 144 Filing | 0001950047-26-007709 | View SEC Doc Filr Page |
| 144 | 2026-08-05 | — | 144 Filing | 0001950047-26-007708 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | FORM 8-K | 0001104659-26-090045 | View SEC Doc Filr Page |